Cargando…

The Mechanical Fingerprint of Circulating Tumor Cells (CTCs) in Breast Cancer Patients

SIMPLE SUMMARY: Detection of circulating tumor cells (CTCs) in the blood of cancer patients is a challenging issue, since they adapt to the biochemical and physical landscape of the bloodstream. We approached the issue of CTC identification on a biophysical level. For the first time, we recorded the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nel, Ivonne, Morawetz, Erik W., Tschodu, Dimitrij, Käs, Josef A., Aktas, Bahriye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961579/ https://www.ncbi.nlm.nih.gov/pubmed/33807790 http://dx.doi.org/10.3390/cancers13051119

Ejemplares similares

Re-evaluation of publicly available gene-expression databases using machine-learning yields a maximum prognostic power in breast cancer
por: Tschodu, Dimitrij, et al.
Publicado: (2023)

Comparative analysis of molecular signatures reveals a hybrid approach in breast cancer: Combining the Nottingham Prognostic Index with gene expressions into a hybrid signature
por: Tschodu, Dimitrij, et al.
Publicado: (2022)

Roadmap to Local Tumour Growth: Insights from Cervical Cancer
por: Kubitschke, Hans, et al.
Publicado: (2019)

Targeted Sequencing of Plasma-Derived vs. Urinary cfDNA from Patients with Triple-Negative Breast Cancer
por: Herzog, Henrike, et al.
Publicado: (2022)

Multi-Parameter Analysis of Disseminated Tumor Cells (DTCs) in Early Breast Cancer Patients with Hormone-Receptor-Positive Tumors
por: König, Theresa, et al.
Publicado: (2023)

Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer
por: Xu, Ying, et al.
Publicado: (2023)

Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
por: Schochter, Fabienne, et al.
Publicado: (2019)

The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
por: Kapeleris, Joanna, et al.
Publicado: (2018)

Heterogeneity between Core Needle Biopsy and Synchronous Axillary Lymph Node Metastases in Early Breast Cancer Patients—A Comparison of HER2, Estrogen and Progesterone Receptor Expression Profiles during Primary Treatment Regime
por: Weydandt, Laura, et al.
Publicado: (2022)

Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs
por: Allen, Joshua E., et al.
Publicado: (2013)

Gauging the Impact of Cancer Treatment Modalities on Circulating Tumor Cells (CTCs)
por: Mathias, Trevor J., et al.
Publicado: (2020)

Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases
por: Mamdouhi, Tania, et al.
Publicado: (2019)

A novel microchannel-based device to capture and analyze circulating tumor cells (CTCs) of breast cancer
por: RIAHI, REZA, et al.
Publicado: (2014)

Dangerous Liaisons: Circulating Tumor Cells (CTCs) and Cancer-Associated Fibroblasts (CAFs)
por: Hurtado, Pablo, et al.
Publicado: (2020)

Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer
por: Mego, Michal, et al.
Publicado: (2016)

Exploring the Role of Hypoxia-Inducible Carbonic Anhydrase IX (CAIX) in Circulating Tumor Cells (CTCs) of Breast Cancer
por: Twomey, Julianne D., et al.
Publicado: (2023)

Detecting heterogeneity in and between breast cancer cell lines
por: Shen, Yang, et al.
Publicado: (2020)

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2019)

Biosensors for the Isolation and Detection of Circulating Tumor Cells (CTCs) in Point-of-Care Settings
por: Goldstein, Isaac, et al.
Publicado: (2023)

Ex vivo expansion of circulating tumour cells (CTCs)
por: Mohamed, Bashir M., et al.
Publicado: (2023)

Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients
por: Weng, Xun, et al.
Publicado: (2022)

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients
por: Aktas, Bahriye, et al.
Publicado: (2009)

Detection of circulating tumor cells (CTCs) in cerebrospinal fluid of a patient with HER2-overexpressing gastric cancer and single cell analysis of intra-patient heterogeneity of CTCs
por: Cho, Jang Ho, et al.
Publicado: (2019)

CTCs Expression Profiling for Advanced Breast Cancer Monitoring
por: Pereira-Veiga, Thais, et al.
Publicado: (2019)

The propensity of invasive circulating tumor cells (iCTCs) in metastatic progression and therapeutic responsiveness
por: Dong, Huan, et al.
Publicado: (2019)

CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs)
por: Tayoun, Tala, et al.
Publicado: (2019)

Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype
por: Wolf, Benjamin, et al.
Publicado: (2023)

Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis
por: Zhu, Hao‐Hua, et al.
Publicado: (2021)

Different prognostic value of circulating and disseminated tumor cells in primary breast cancer: Influence of bisphosphonate intake?
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2016)

Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients
por: Zhang, Xi, et al.
Publicado: (2017)

Immune Checkpoint and EMT-Related Molecules in Circulating Tumor Cells (CTCs) from Triple Negative Breast Cancer Patients and Their Clinical Impact
por: Vardas, Vasileios, et al.
Publicado: (2023)

Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
por: Aktas, Bahriye, et al.
Publicado: (2016)

Molecular characterization of breast cancer CTCs associated with brain metastasis
por: Boral, Debasish, et al.
Publicado: (2017)

Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response
por: Liu, Jialing, et al.
Publicado: (2021)

Novel method for highly multiplexed gene expression profiling of circulating tumor cells (CTCs) captured from the blood of women with metastatic breast cancer
por: Farhang Ghahremani, Morvarid, et al.
Publicado: (2023)

Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
por: Kejík, Zdeněk, et al.
Publicado: (2021)

Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)
por: Lim, Minji, et al.
Publicado: (2018)

Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer
por: Bredemeier, Maren, et al.
Publicado: (2017)

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
por: Serrano, Maria J., et al.
Publicado: (2014)

TLR4 and pSTAT3 Expression on Circulating Tumor Cells (CTCs) and Immune Cells in the Peripheral Blood of Breast Cancer Patients: Prognostic Implications
por: Papadaki, Maria A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_18mkfe86oiau2cncec0j4413g2